Shopping Cart
- Remove All
- Your shopping cart is currently empty
EZ-482 is an apolipoprotein (apoE) ligand that binds to the C-terminal domain of apoE3 and apoE4 through a unique N-terminal allosteric effect, useful in Alzheimer's disease research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $116 | In Stock | |
50 mg | $789 | 6-8 weeks | |
100 mg | $1,320 | 6-8 weeks |
Description | EZ-482 is an apolipoprotein (apoE) ligand that binds to the C-terminal domain of apoE3 and apoE4 through a unique N-terminal allosteric effect, useful in Alzheimer's disease research. |
Targets&IC50 | ApoE3/ApoE4:~8 μM (Ki) |
In vitro | The dissociation constant of EZ-482 from apoE3 and apoE4 is about 8 μM. EZ-482 (10 or 20 μM) does not directly affect apoE binding to lipids. [1] |
In vivo | In combination with anti-PD-1, EZ-482 (administered daily by oral force-feeding at a concentration of 15 mg/kg) reversed M2-EXO-induced ICB resistance in a mouse model of MC38 tumors.[2] |
Alias | EZ482 |
Molecular Weight | 498.94 |
Formula | C23H19ClN4O5S |
Cas No. | 1016456-76-0 |
Smiles | O=C(NC1=CC(=CC=C1O)S(=O)(=O)NC=2C=CC=C(Cl)C2)CC3=NN(C(=O)C=4C=CC=CC43)C |
Relative Density. | 1.49 g/cm3 (Predicted) |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 60 mg/mL (120.25 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.